Search research articles
Contact Us
Filters
Showing results (831-840 of 849) with videos related to
Page
of 85
Sort By:
Nature Cell Biology
|
May 6, 2020
Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity
Yi Huang, Huanyu Wang, Yize Hao, et al.
Cancer Science
|
July 30, 2021
Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer
Satoru Iwasa, Kei Muro, Satoshi Morita, et al.
Journal of Cellular Biochemistry
|
February 16, 2012
Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads
Ya-Lan Tao, Yan Li, Jin Gao, et al.
British Journal of Sports Medicine
|
April 29, 2025
Impact of exercise on health outcomes in people with cancer: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials
Xue-Li Bai, Yu Li, Zan-Fei Feng, et al.
JAMA Network Open
|
March 13, 2026
Mailed Audit and Feedback for Antibiotic Prescribing in Primary Care
Lisa Masucci, Kevin Schwartz, Noah Ivers, et al.
The Journal of Antimicrobial Chemotherapy
|
June 18, 2026
Safety of antibiotic audit and feedback: secondary analysis of a randomized controlled trial
Kevin L Schwartz, Li Bai, Kevin A Brown, et al.
Canadian Family Physician Medecin De Famille Canadien
|
October 15, 2024
Characteristics of walk-in clinic physicians and patients in Ontario: Cross-sectional study
Lauren Lapointe-Shaw, Christine Salahub, Peter C Austin, et al.
Journal of Ethnopharmacology
|
July 3, 2025
The efficacy and safety of Yiqi Huoxue Huatan granule in the treatment of stable COPD with chronic respiratory failure: A randomized, double-blind, placebo controlled trial
Jia-Yi Yang, Hong-Tao Wang, Ke-Ming Zhao, et al.
Frontiers in Oncology
|
March 21, 2022
A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy
Maosong Ye, Lin Tong, Xiaoxuan Zheng, et al.
The Lancet. Oncology
|
May 11, 2025
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
Jian Zhou, Li Bai, Jia Luo, et al.
Page
of 85
Search research articles
Search
Showing results (831-840 of 849) with videos related to
Sort By:
Page
of 85
Nature Cell Biology
|
May 6, 2020
Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity
Yi Huang, Huanyu Wang, Yize Hao, et al.
Cancer Science
|
July 30, 2021
Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer
Satoru Iwasa, Kei Muro, Satoshi Morita, et al.
Journal of Cellular Biochemistry
|
February 16, 2012
Identifying FGA peptides as nasopharyngeal carcinoma-associated biomarkers by magnetic beads
Ya-Lan Tao, Yan Li, Jin Gao, et al.
British Journal of Sports Medicine
|
April 29, 2025
Impact of exercise on health outcomes in people with cancer: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials
Xue-Li Bai, Yu Li, Zan-Fei Feng, et al.
JAMA Network Open
|
March 13, 2026
Mailed Audit and Feedback for Antibiotic Prescribing in Primary Care
Lisa Masucci, Kevin Schwartz, Noah Ivers, et al.
The Journal of Antimicrobial Chemotherapy
|
June 18, 2026
Safety of antibiotic audit and feedback: secondary analysis of a randomized controlled trial
Kevin L Schwartz, Li Bai, Kevin A Brown, et al.
Canadian Family Physician Medecin De Famille Canadien
|
October 15, 2024
Characteristics of walk-in clinic physicians and patients in Ontario: Cross-sectional study
Lauren Lapointe-Shaw, Christine Salahub, Peter C Austin, et al.
Journal of Ethnopharmacology
|
July 3, 2025
The efficacy and safety of Yiqi Huoxue Huatan granule in the treatment of stable COPD with chronic respiratory failure: A randomized, double-blind, placebo controlled trial
Jia-Yi Yang, Hong-Tao Wang, Ke-Ming Zhao, et al.
Frontiers in Oncology
|
March 21, 2022
A Classifier for Improving Early Lung Cancer Diagnosis Incorporating Artificial Intelligence and Liquid Biopsy
Maosong Ye, Lin Tong, Xiaoxuan Zheng, et al.
The Lancet. Oncology
|
May 11, 2025
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
Jian Zhou, Li Bai, Jia Luo, et al.
Page
of 85